Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05550194 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

VZV in the Enteric Nervous System: Pathogenesis and Consequences

StatusRecruiting
PhasePhase 4
Started2023-03-27
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 27, 2026 (before its estimated August 2026 completion). Its status may not reflect the trial's current state.

Amendment history

2026-05-22
minor
3 amendments v3-v5
3 re-verifications since 2024-04-11, no change to tracked fields
2023-03-30
notable
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v2
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2023-03→confirmed 2023-03-27
Study sites0→1
2023-01-17
minor
Study Status v1
Start date2022-12→2023-03
2022-09-19
minor
Original filing
Varicella zoster virus (VZV) is the cause of chickenpox and shingles, but it also infects, becomes latent, and reactivates in nerve cells of the bowel to cause a gastrointestinal disorder ("enteric shingles"). The Investigators recently found that a chronic active VZV infection, a form of enteric shingles, is associated with achalasia, a severe disease in which the passage of food from esophagus to stomach is impaired. We now propose to eradicate VZV to determine whether its association with achalasia is causal, to identify the genetic basis behind VZV reactivation in the esophagus, and the relationship of mast cells to enteric shingles and abdominal pain.
Trial Details
NCT Number NCT05550194
Lead Sponsor Vanderbilt University Medical Center
Collaborators: Columbia University
Conditions Achalasia
Enrollment 40 participants
Start Date 2023-03-27
Primary Completion 2026-08 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2026-05-27